KYTX · Stage, GEX levels and seasonality

Kyverna Therapeutics, Inc. Common Stock (KYTX)

Last close $6.18 (+0.16%) on 2026-10-08

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Weinstein stage

Stage 4B — Declining · 3 weeks in this stage · 30-week average $8.13

Stage 4 (declining): price stays below a falling 30-week average. The stage Weinstein avoids.

What would change it: Stage 1 begins if the 30-week SMA (8.13) stops declining while price works around it, or after 3 straight weekly closes above it.

GEX levels

Put wall	Gamma flip	Call wall
5	6.51	10

Set before the open on 2026-10-02. Members see today's levels, updated every 15 minutes. How to read GEX.

Seasonality

Month	Average return	Months up	Years
January	-14.82%	0%	2
February	-4.92%	50%	2
March	-10.91%	33%	3
April	-7.82%	33%	3
May	-3.31%	33%	3
June	-8.53%	67%	3
July	+0.4%	33%	3
August	+10.54%	100%	3
September	-6.05%	33%	3
October (this month)	+15.94%	100%	2
November	+14.02%	100%	2
December	-7.3%	50%	2

Based on up to 3 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for KYTX, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about KYTX

What Weinstein stage is KYTX in?

KYTX is in Stage 4B — Declining, for 3 weeks, based on completed weekly bars and its 30-week moving average (8.13).

How has KYTX done in October?

Over the last 2 years, KYTX averaged +15.94% in October and rose in 100% of them. Past seasonality does not predict future returns.

What are KYTX's GEX levels?

Before the open on 2026-10-02, KYTX's put wall was 5, gamma flip 6.51 and call wall 10. Signa members see today's levels, updated every 15 minutes.

Educational content only, not financial advice. Trading involves substantial risk.